Structure

InChI Key WANIDIGFXJFFEL-SANMLTNESA-N
Smile Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1
InChI
InChI=1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C27H22F4N6O3S
Molecular Weight 586.57
AlogP 4.06
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 5.0
Polar Surface Area 102.98
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 41.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Glucocorticoid receptor antagonist Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Adrenocortical Hyperfunction 3 D000308 ClinicalTrials
Carcinoma, Pancreatic Ductal 3 D021441 ClinicalTrials
Cushing Syndrome 3 D003480 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Fallopian Tube Neoplasms 2 D005185 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Adrenal Cortex Neoplasms 1 D000306 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1496510-51-0
ChEMBL CHEMBL4068611
DrugBank DB14976
FDA SRS 2158753C7E
PubChem 73051463
SureChEMBL SCHEMBL15454999
ZINC ZINC000141949519